CELU Stock Summary and Trading Ideas (Celularity - Class A | NASDAQ:CELU)

Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.

Celularity - Class A trades on the NASDAQ stock market under the symbol CELU.

As of August 10, 2026, CELU stock price declined to $0.69 with 25,510 million shares trading.

CELU has a beta of 1.48, meaning it tends to be more sensitive to market movements. CELU has a correlation of 0.05 to the broad based SPY ETF.

CELU has a market cap of $19.55 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, CELU traded as high as $7.97 and as low as $.56.

The top ETF exchange traded funds that CELU belongs to (by Net Assets): VTI, VXF.

CELU has underperformed the market in the last year with a price return of -78.8% while the SPY ETF gained +22.5%. CELU has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -22.0% and -8.6%, respectively, while the SPY returned +5.1% and +4.6%, respectively.

CELU support price is $.65 and resistance is $.76 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CELU shares will trade within this expected range on the day.